Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
11/13/2003 | WO2003092471A2 Cell-seeded extracellular matrix grafts |
11/13/2003 | WO2003092381A1 Vascularization enhanced graft constructs |
11/13/2003 | WO2003075826A3 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma(obstructive lung disease) |
11/13/2003 | WO2003075825A3 The method of treating tuberculosis |
11/13/2003 | WO2003057853A3 Oxidative stress-resistant cell lines and methods of use thereof |
11/13/2003 | WO2003048347A9 Periosteal distraction |
11/13/2003 | WO2003042244A3 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts |
11/13/2003 | WO2003042113A8 Production of cell suspensions |
11/13/2003 | WO2003032948A3 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
11/13/2003 | WO2003029436A3 Ul16 binding protein 4 |
11/13/2003 | WO2003028536A3 Methods for diagnosing and treating heart disease |
11/13/2003 | WO2003022215A3 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response |
11/13/2003 | WO2003000889A3 Identification of ses-1 and the uses of the same |
11/13/2003 | WO2002067956A3 Method for purifying a biological composition |
11/13/2003 | WO2002061033A3 Transfection of human embryonic stem cells |
11/13/2003 | WO2002057302A8 A virus causing respiratory tract illness in susceptible mammals |
11/13/2003 | US20030213003 Preparing and recoverng genetically engineered fusion protein for treating diabetes |
11/13/2003 | US20030212044 Treatment of HIV |
11/13/2003 | US20030212041 Facilitation of wound healing with CM101/GBS toxin |
11/13/2003 | US20030212030 Blood disorders; synergistic mixture of vector and monoclonal antibody |
11/13/2003 | US20030212026 Induce immunology response |
11/13/2003 | US20030212024 Compositions and methods for cell dedifferentiation and tissue regeneration |
11/13/2003 | US20030211927 Blood processing chamber counter-balanced with blood-free liquid |
11/13/2003 | US20030211603 Using mixture of pluripotent cells to alter fate of differentiated tissues; tissue engineering; tissue regeneration |
11/13/2003 | US20030211602 Obtaining, monitoring and differentiating between cultured pluripotent progenitor cells; for use in treatment of bone, diabetic and eating disorders; wound healing agents |
11/13/2003 | US20030211601 Isolated bladder submucosa for tissue reconstruction |
11/13/2003 | US20030211592 Methods of terminal sterilization of biological products |
11/13/2003 | US20030211467 Using monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy; genetic vaccine |
11/13/2003 | US20030211226 Heating with ginger root; drying; cyclic process |
11/13/2003 | US20030211178 Herbal composition for treatment of neuronal injuries and neuronal degeneration, methods to prepare the same and uses thereof |
11/13/2003 | US20030211130 Bioengineered tissue substitutes |
11/13/2003 | US20030211115 Adjuvant compositions for mucosal and injection delivered vaccines |
11/13/2003 | US20030211100 Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
11/13/2003 | US20030211098 Pretreatment of animal with antibodies to sensitize animal; controlling dosage |
11/13/2003 | US20030211097 Epidermal growth factor; antitumor, anticancer agents |
11/13/2003 | US20030211088 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same |
11/13/2003 | US20030211085 Cell therapy for chronic stroke |
11/13/2003 | US20030211083 Injectable microspheres for tissue construction |
11/13/2003 | US20030209617 Eggshell waste processing method and device |
11/13/2003 | CA2493957A1 Method of enhancing biological activity of plant extracts |
11/13/2003 | CA2493944A1 Isolation of target cells, capillaries and microorgans |
11/13/2003 | CA2484940A1 Methods and compositions for the modification of nucleic acids |
11/13/2003 | CA2484614A1 Cell-seeded extracellular matrix grafts |
11/13/2003 | CA2484287A1 Pharmaceutical- or gene-carrier compositions with reduced hemagglutinating activity |
11/13/2003 | CA2483915A1 Vectors having both isoforms of b-hexosaminidase |
11/13/2003 | CA2483913A1 Vascularization enhanced graft constructs comprising basement membrane |
11/13/2003 | CA2483683A1 Vascularization enhanced graft constructs |
11/13/2003 | CA2483050A1 Optimization of transgene expression in mammalian cells |
11/13/2003 | CA2482780A1 Apparatus and method for delivery of constrained beneficial bacteria to the vaginal tract |
11/13/2003 | CA2480008A1 Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine |
11/12/2003 | EP1361277A1 Optimization of transgene expression in mammalian cells |
11/12/2003 | EP1361269A1 Delivery of gene products via mesangial cells expressing an exogenous gene |
11/12/2003 | EP1361268A1 Pax-5-deficient pro-B cells, methods of producing them and the use of such cells in human therapy |
11/12/2003 | EP1361267A2 Mesenchymal stem cells and their use |
11/12/2003 | EP1361266A1 Transplantation cell kits for re-myelination in nerve cells |
11/12/2003 | EP1360307A2 Chimeric polypeptides of serum albumin and uses related thereto |
11/12/2003 | EP1360299A2 The genome of a bifidobacterium |
11/12/2003 | EP1360277A2 Multipotent o-2a progenitors from the neurohypophysis |
11/12/2003 | EP1360208A1 Induvidualized anti-cancer antibodies |
11/12/2003 | EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
11/12/2003 | EP1360202A2 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
11/12/2003 | EP1359947A2 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
11/12/2003 | EP1359924A1 Endotoxin binding by lactic acid bacteria and bifidobacteria |
11/12/2003 | EP1359816A1 Combination of probiotics |
11/12/2003 | EP1304114A9 Adsorbent for endocrine disruptors and foods and drinks containing the same |
11/12/2003 | EP1146895B1 Thrombopoietin compositions for increasing circulating platelets |
11/12/2003 | EP1133308B1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases |
11/12/2003 | EP1109462B1 Method for obtaining avian biological products |
11/12/2003 | EP1051187B1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway |
11/12/2003 | EP1011696B1 Treatment of stress and preconditioning against stress |
11/12/2003 | EP0936917B1 Prevention of gastrointestinal damage |
11/12/2003 | EP0815867B1 Cells for treating dementia |
11/12/2003 | EP0775203B1 Method of gene therapy using dna vectors without selection marker gene |
11/12/2003 | CN1455816A Rescue of canine distemper virus from CDNA |
11/12/2003 | CN1455682A Compositions for gene therapy of rheumatoid arthritis including gene encoding anti-angiogenic protein or parts thereof |
11/12/2003 | CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine |
11/12/2003 | CN1455673A Antibiotics from bacteria isolated from amphibian skin and biological active extrat derivated from same |
11/12/2003 | CN1454666A Medicine composition, preparing method thereof and its use for preparing medicines for curing SARS and SARS-induced cardio-cerebro complication |
11/12/2003 | CN1454646A Chinese medicine preparation for curing osteoporosis and preparing method thereof |
11/12/2003 | CN1454635A Eight-ingredient stomach-regulating oral liquid and preparing process thereof |
11/12/2003 | CN1454634A Capsule for curing asynodia, spermatorrhea, nephralgia and osphyalgia |
11/12/2003 | CN1454629A Medicine for clinical hemostasis and preparing method thereof |
11/12/2003 | CN1454628A Chinese medicine decoction for curing fatty liver |
11/12/2003 | CN1454626A Chinese herbal medicine for enhancing immunity |
11/12/2003 | CN1454617A Body-building fast-acting hair-growing compound instant particles and preparing method thereof |
11/12/2003 | CN1454616A Medicine for curing haemorrhoids |
11/12/2003 | CN1454608A Medicine for preventing and curing cerebrovascular dementia |
11/12/2003 | CN1454607A Medicine for curing cervicitis and preparing method thereof |
11/12/2003 | CN1454513A Extraction of water soluble organic calcium from egg shell of birds and preparation of two-calcium nutrient intensifying liguor |
11/12/2003 | CN1127517C Trophic fuctors for central nervous system |
11/12/2003 | CN1127351C Method for inducing antigen-specific T cell tolerance |
11/12/2003 | CN1127347C Medicine for curing hyperosteogeny |
11/12/2003 | CN1127346C Leukoderma treating externally-used medicine |
11/12/2003 | CN1127344C Oral pill for treating diabetes and its complication |
11/12/2003 | CN1127343C Myoblast therapy for mammalian diseases |
11/11/2003 | US6645948 Nutritional composition for the treatment of connective tissue |
11/11/2003 | US6645935 Synthesis of glycoconjugates of the lewis Y epitope and uses thereof |
11/11/2003 | US6645764 Neocartilage and methods of use |
11/11/2003 | US6645715 Artificial cornea |
11/11/2003 | US6645530 Treatment of gastro-intestinal disorders |